Loading…

WuXi AppTec plans to expand its facilities in San Diego, establishing a center of excellence in screening, discovery biology, pharmacology, and small molecule process R&D including Phase I GMP manufacturing. The article does not specify investment amount or timeline.
“Having a leading global organization like WuXi significantly invest in San Diego highlights the value of international partnerships.”biospace.com
Summarized from public sources; check the original articles before acting on it.